<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" 
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
  <url>
    <loc>https://openbell.ai/</loc>
    <lastmod>2026-10-08T12:58:23.831Z</lastmod>
    <changefreq>hourly</changefreq>
    <priority>1.0</priority>
  </url>
  <url>
    <loc>https://openbell.ai/support</loc>
    <lastmod>2026-10-08T12:58:23.831Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://openbell.ai/privacy</loc>
    <lastmod>2026-10-08T12:58:23.831Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://openbell.ai/terms</loc>
    <lastmod>2026-10-08T12:58:23.831Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://openbell.ai/feed.json</loc>
    <lastmod>2026-10-08T12:58:23.831Z</lastmod>
    <changefreq>hourly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://openbell.ai/news/LLY:1791464282118</loc>
    <lastmod>2026-10-08T12:58:02.118Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/LLY/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Eli Lilly To Rally Over 21%? Here Are 10 Top Analyst Forecasts For Thursday</image:title>
      <image:caption>Cantor Fitzgerald raised the price target for Eli Lilly and Company (NYSE: LLY) from $1,410 to $1,440 while maintaining an Overweight rating. Eli Lilly shares closed at $1,188.72 on Wednesday. This adjustment reflects positive analyst sentiment towards the company&#39;s performance and future prospects.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/HELE:1791464198096</loc>
    <lastmod>2026-10-08T12:56:38.096Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/HELE/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Helen of Troy shares are trading higher after the company reported better-than-expected Q2 adjusted EPS results and raised its FY27 GAAP EPS guidance.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/BETR:1791464157587</loc>
    <lastmod>2026-10-08T12:55:57.587Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/BETR/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Better Home &amp;amp; Financing Announces $30M Buyback Plan</image:title>
      <image:caption>Better Home &amp; Finance Holding Company (NASDAQ: BETR) has announced a $30 million buyback plan for its Class A common stock, as authorized by its Board of Directors. The company plans to initiate the buyback with an initial phase of $10 million.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/PEP:1791464139978</loc>
    <lastmod>2026-10-08T12:55:39.978Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/PEP/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>PepsiCo Admits Its Soda Business Is Falling Behind Rivals</image:title>
      <image:caption>PepsiCo reported third-quarter net revenue of $25.27 billion, a 5.6% increase year-over-year, surpassing analysts&#39; expectations. However, the company lowered its fiscal 2026 earnings outlook, projecting adjusted earnings per share between $8.34 and $8.43, below the $8.55 consensus estimate. North American operations are facing margin pressures, prompting PepsiCo to implement cost-cutting measures while emphasizing growth in international markets, which saw an 8% increase in organic revenue. The stock rose 1.72% to $125.86 in premarket trading.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/SPCX:1791464133564</loc>
    <lastmod>2026-10-08T12:55:33.564Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/SPCX/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Elon Musk’s SpaceX Could Pay Off for Investors Before Tesla Ever Did, Says Jim Cramer — Top Investment Bank Sees Over 37% Upside for SPCX Investors (UPDATED)</image:title>
      <image:caption>Jim Cramer has highlighted SpaceX (NASDAQ: SPCX) as a promising investment, suggesting it could yield returns for investors before Tesla does. Goldman Sachs has raised its price target for SpaceX to $230, indicating over 37% upside from its last closing price, while Morgan Stanley has issued a price target of $300, citing the company&#39;s unique investment opportunities. Cramer noted that SpaceX is generating significant revenue from renting out AI compute resources and plans to borrow $40 billion to purchase more NVIDIA chips.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/SPCX:1791464069571</loc>
    <lastmod>2026-10-08T12:54:29.571Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/SPCX/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Elon Musk’s SpaceX Could Pay Off for Investors Before Tesla Ever Did, Says Jim Cramer — Top Investment Bank Sees Over 37% Upside for SPCX Investors</image:title>
      <image:caption>Jim Cramer has highlighted SpaceX (NASDAQ: SPCX) as a promising investment, suggesting it could yield returns for investors before Tesla. Goldman Sachs has raised its price target for SpaceX to $230, indicating over 37% upside from its last closing price, while Morgan Stanley has set a target of $300, citing the company&#39;s unique business opportunities. Cramer noted SpaceX&#39;s profitability from renting AI compute resources and its potential to become NVIDIA&#39;s largest client, further enhancing its investment appeal.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/PEP:1791464058026</loc>
    <lastmod>2026-10-08T12:54:18.026Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/PEP/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>PepsiCo Admits Its Soda Business Is Falling Behind Rivals</image:title>
      <image:caption>PepsiCo reported third-quarter net revenue of $25.27 billion, a 5.6% increase year-over-year, surpassing analysts&#39; expectations. However, the company lowered its fiscal 2026 earnings outlook, projecting adjusted earnings per share between $8.34 and $8.43, below the $8.55 consensus estimate. North American operations continue to face margin pressure, prompting PepsiCo to implement cost-cutting measures and focus on faster-growing product categories. Despite challenges in its soda business, international operations showed strong growth, with an 8% increase in organic revenue.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/TXO:1791463949319</loc>
    <lastmod>2026-10-08T12:52:29.319Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/TXO/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Stephens &amp;amp; Co. Initiates Coverage On TXO Partners with Overweight Rating, Announces Price Target of $22</image:title>
      <image:caption>Stephens &amp; Co. analyst Mike Scialla has initiated coverage on TXO Partners (NYSE: TXO) with an Overweight rating. The firm has set a price target of $22 for the stock.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/NVDA:1791463939666</loc>
    <lastmod>2026-10-08T12:52:19.666Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/08/Elon-Musk-is-the-founder--CEO--and-Chief.jpg?width=250&amp;height=187</image:loc>
      <image:title>Elon Musk’s SpaceX Could Become Nvidia’s Biggest Customer: The ETF Trade Emerging From His $40B AI Bet</image:title>
      <image:caption>SpaceX is seeking $40 billion in financing to purchase Nvidia chips as part of its AI data-center expansion, which includes $10 billion in bank loans and $30 billion in investment-grade debt. This move could position SpaceX as Nvidia&#39;s largest customer, with potential monthly revenues of $3 billion to $4 billion from renting computing capacity. The planned increase in computing capacity from 1.4 gigawatts to 15 gigawatts by the end of 2027 may significantly boost demand for Nvidia&#39;s data-center business.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/GNRC:1791463865317</loc>
    <lastmod>2026-10-08T12:51:05.317Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/GNRC/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Generac Holdings shares are trading higher after Keybanc upgraded the stock from Sector Weight to Overweight. Also, Piper Sandler initiated coverage on the stock with an Overweight rating and announced a $303 price target.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/FTW:1791463833430</loc>
    <lastmod>2026-10-08T12:50:33.430Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/FTW/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Stephens &amp;amp; Co. Initiates Coverage On Presidio Production with Overweight Rating, Announces Price Target of $15</image:title>
      <image:caption>Stephens &amp; Co. analyst Mike Scialla has initiated coverage on Presidio Production (NYSE: FTW) with an Overweight rating. The firm has set a price target of $15 for the stock.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/OGS:1791463831679</loc>
    <lastmod>2026-10-08T12:50:31.679Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/OGS/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Jefferies Downgrades ONE Gas to Hold, Lowers Price Target to $80</image:title>
      <image:caption>Jefferies analyst Julien Dumoulin-Smith has downgraded ONE Gas (NYSE: OGS) from a Buy rating to Hold. The price target for the stock has also been reduced from $103 to $80.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/VXRT:1791463740369</loc>
    <lastmod>2026-10-08T12:49:00.369Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/VXRT/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Vaxart Announces Publication Of Preclinical Study Results Evaluating Its Oral Mucosal Vaccine Platform Against Highly Pathogenic Avian Influenza H5N1; Candidate VXA-H5-02 Induced Robust Cross-Neutralizing Antibodies</image:title>
      <image:caption>Vaxart has published positive preclinical study results for its oral mucosal vaccine candidate VXA-H5-02 against Highly Pathogenic Avian Influenza H5N1, demonstrating a 100% survival rate in immunized ferrets following a lethal challenge. The study, published in Frontiers in Immunology, highlighted significant reductions in viral load and shedding, as well as robust mucosal and systemic antibody responses. VXA-H5-02 also showed cross-neutralizing activity against various H5 strains, indicating potential for broader protection.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/MMED:1791463628141</loc>
    <lastmod>2026-10-08T12:47:08.141Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/MMED/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Mizuho Maintains Outperform on Minimed Group, Raises Price Target to $28</image:title>
      <image:caption>Mizuho analyst Anthony Petrone has maintained an &#39;Outperform&#39; rating on Minimed Group (NASDAQ: MMED) and raised the price target from $26 to $28. This adjustment reflects a positive outlook for the company&#39;s performance in the market.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/H:1791463563359</loc>
    <lastmod>2026-10-08T12:46:03.359Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/H/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Mizuho Maintains Outperform on Hyatt Hotels, Raises Price Target to $222</image:title>
      <image:caption>Mizuho analyst Ben Chaiken has maintained an Outperform rating on Hyatt Hotels (NYSE: H) and raised the price target from $221 to $222. This adjustment reflects a positive outlook for the company in the market.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/NESR:1791463492681</loc>
    <lastmod>2026-10-08T12:44:52.681Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/08/Dhahran--Saudi-Arabia--January-3--2024-S.jpg?width=250&amp;height=187</image:loc>
      <image:title>NESR To Deliver Saudi Arabia&amp;#39;s First Direct Lithium Extraction Project</image:title>
      <image:caption>National Energy Services Reunited Corp. (NASDAQ: NESR) has entered into a five-year agreement with Saudi Aramco to deliver the region&#39;s first direct lithium extraction project, valued at approximately $200 million. The project aims to produce 2,000 tons per annum of battery-grade lithium carbonate, with commissioning and production expected by late 2027. NESR shares rose nearly 3% to $24.30 in premarket trading, although they remain significantly below key moving averages, indicating ongoing selling pressure.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/TCBX:1791463440873</loc>
    <lastmod>2026-10-08T12:44:00.873Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/TCBX/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>StoneX Maintains Buy on Third Coast Bancshares, Raises Price Target to $56</image:title>
      <image:caption>StoneX analyst Brett Rabatin has maintained a &#39;Buy&#39; rating on Third Coast Bancshares (NYSE: TCBX) and raised the price target from $54 to $56.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/INIO:1791463248485</loc>
    <lastmod>2026-10-08T12:40:48.485Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/INIO/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>INNIO Extends Partnership With Aggreko To Secure Substantial Long-Term Engine Capacity For Aggreko While Providing The Company With Order Visibility For Medium-Power Range Engines Through 2031</image:title>
      <image:caption>INNIO has extended its partnership with Aggreko to provide a minimum of 450 MW of medium-power range engine capacity through 2027, with additional capacity levels agreed upon for the duration of the agreement. The partnership includes a multi-year service agreement for Aggreko&#39;s existing INNIO fleet and will now also supply the J620 engine starting in 2028. This collaboration focuses on INNIO&#39;s Jenbacher Type 4 platform, which is designed for rapid deployment and reliable operation in various industrial applications.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/INIO:1791463237377</loc>
    <lastmod>2026-10-08T12:40:37.377Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/INIO/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>INNIO Collaborates With Aggreko Over Long-Term Engine Capacity For Aggreko Through 2031</image:title>
      <image:caption>INNIO N.V. has extended its strategic partnership with Aggreko through 2031, ensuring long-term engine capacity for Aggreko. This agreement enhances INNIO&#39;s order visibility for medium-power range engines, reinforcing their collaboration in engineered energy solutions.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/MBAI:1791463185160</loc>
    <lastmod>2026-10-08T12:39:45.160Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/MBAI/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>MBody AI Files Two Patent Applications Covering Orchestrator Robot Management Platform And Autonomous Equipment Operation In Extreme Heat</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/SRXH:1791463146086</loc>
    <lastmod>2026-10-08T12:39:06.086Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/SRXH/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>SRX Global Announces $2.5M Initial Investment To Seed Multi-Strategy Trading Fund In Joint Venture With 5T Trading</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/NUE:1791463100401</loc>
    <lastmod>2026-10-08T12:38:20.401Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/NUE/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Nucor To Expand Production At Its Towers &amp;amp; Structures Facility In Indiana Under Additional $105M Investment; Expected To Create 100 New Jobs</image:title>
      <image:caption>Nucor Corporation is investing an additional $105 million to expand its Towers &amp; Structures facility in Indiana, adding over 120,000 square feet of manufacturing space. This expansion will incorporate advanced automation and modern production technologies, aimed at increasing production capacity and efficiency. The investment is expected to create 100 new jobs, enhancing the current workforce of 328 employees at the facility.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/FTNT:1791463060611</loc>
    <lastmod>2026-10-08T12:37:40.611Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/FTNT/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Amerx Initiates Coverage On Fortinet with Overweight Rating, Announces Price Target of $240</image:title>
      <image:caption>Amerx analyst Casey Ryan has initiated coverage on Fortinet (NASDAQ: FTNT) with an Overweight rating. The analyst has set a price target of $240 for the company&#39;s stock.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/QXL:1791462999597</loc>
    <lastmod>2026-10-08T12:36:39.597Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/QXL/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Quantum X Labs Files U.S. Patent Application Titled &amp;#39;Structured-Beam Zeeman Slower And Atomic Push-Beam System&amp;#39; For The Cooling, Manipulation And Transport Of Neutral Atoms</image:title>
      <image:caption>Quantum X Labs has filed a U.S. patent application for a &#39;Structured-Beam Zeeman Slower And Atomic Push-Beam System&#39; aimed at enhancing the cooling, manipulation, and transport of neutral atoms. This technology is part of their cold-atom quantum computing program, focusing on improving the control of atomic beams using structured optical beams instead of traditional Gaussian profiles. The application seeks to advance the foundational technologies necessary for preparing atoms for quantum operations, which are critical for the development of cold-atom quantum computers.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/ASNS:1791462985526</loc>
    <lastmod>2026-10-08T12:36:25.526Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/ASNS/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Actelis Networks Announces U.S. Marine Corps Purchase Order For VoIP Network Across 65 Buildings; ~$500K Total Program Includes Integrator Services</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/ZS:1791462978791</loc>
    <lastmod>2026-10-08T12:36:18.791Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/ZS/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Amerx Initiates Coverage On Zscaler with Buy Rating, Announces Price Target of $305</image:title>
      <image:caption>Amerx analyst Casey Ryan has initiated coverage on Zscaler (NASDAQ: ZS) with a Buy rating and set a price target of $305 for the stock. This marks a positive outlook for Zscaler in the market.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/FBDT:1791462977036</loc>
    <lastmod>2026-10-08T12:36:17.036Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/FBDT/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>First Breach Expands Recruitment Initiative To Support  Increased Ammunition Production, Planned Buildout Of Its Drone Manufacturing Operations In Maryland</image:title>
      <image:caption>First Breach Inc. (NASDAQ: FBDT) has announced an expanded recruitment initiative aimed at supporting increased ammunition production and the planned expansion of its drone manufacturing operations in Hagerstown, Maryland. This initiative is designed to enhance the company&#39;s workforce as it scales its ammunition business and develops capabilities for its unmanned systems programs.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/CJMB:1791462949449</loc>
    <lastmod>2026-10-08T12:35:49.449Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/CJMB/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Callan JMB Signs Initial Purchase Order For ~$28M Of Pharmaceutical Manufacturing Equipment From TRUKING; To Serve As North American Distributor</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/BKSY:1791462928143</loc>
    <lastmod>2026-10-08T12:35:28.143Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/BKSY/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>BlackSky Technology Receives Six Figure Gen-3 On-Demand Pilot Imagery Services Contract</image:title>
      <image:caption>BlackSky Technology Inc. (NYSE: BKSY) has secured a six-figure contract for Gen-3 On-Demand pilot imagery services with a new international intelligence customer. This contract enhances the company&#39;s operational presence with a significant sovereign partner in a strategically important region.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/SSNFL:1791462896720</loc>
    <lastmod>2026-10-08T12:34:56.720Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/08/3d-Letter-Samsung-In-High-Technology.jpg?width=250&amp;height=187</image:loc>
      <image:title>Samsung’s $80B Quarterly Profit Tops Nvidia, AMD’s Lisa Su Shops In Seoul</image:title>
      <image:caption>Samsung Electronics reported a third-quarter operating profit of approximately 107.4 trillion won (about $80.2 billion), surpassing Nvidia&#39;s profit of $63.7 billion by roughly $16 billion or 26%. The company&#39;s revenue is expected to reach a record 195 trillion won (about $146 billion), reflecting a 127% increase year-over-year. Despite these strong financial results, Samsung&#39;s shares fell by 2.4% due to revenue estimates slightly missing expectations and the impact of a stronger won on overseas sales.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/NXL:1791462895740</loc>
    <lastmod>2026-10-08T12:34:55.740Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/NXL/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Nexalin Technology Says It Regained Compliance With Nasdaq Minimum Bid Price Rule; Must Meet $2.5M Stockholders&amp;#39; Equity Requirement By January 4, 2027</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/TOMZ:1791462857936</loc>
    <lastmod>2026-10-08T12:34:17.936Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/TOMZ/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>TOMI Environmental Solutions Reports Preliminary Q3 Revenue Of $2.5M, Up 27%; Says It Is Evaluating Potential Merger Candidates</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/CRSP:1791462833850</loc>
    <lastmod>2026-10-08T12:33:53.850Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/CRSP/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>CRISPR Therapeutics To Present Phase 1b Data For CTX310 In Severe Hypertriglyceridemia In Late-Breaking AHA Presentation On November 9</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/VIR:1791462812054</loc>
    <lastmod>2026-10-08T12:33:32.054Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/VIR/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Vir Biotechnology Receives FDA Fast Track Designation For VIR-5500 To Treat Metastatic Castration-Resistant Prostate Cancer</image:title>
      <image:caption>Vir Biotechnology, Inc. (Nasdaq: VIR) has received Fast Track designation from the FDA for its product VIR-5500, aimed at treating metastatic castration-resistant prostate cancer (mCRPC). VIR-5500 is a PSMA-targeted PRO-XTEN® dual-masked T-cell engager, developed in collaboration with Astellas Pharma Inc. This designation may expedite the development and review process for the treatment.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/SPCX:1791462802922</loc>
    <lastmod>2026-10-08T12:33:22.922Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/SPCX/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Jeff Bezos Hints at Blue Origin IPO After $10 Billion Funding Round — Amazon Founder Says It ‘Makes Sense’ for SpaceX Rival to Go &amp;#39;Public&amp;#39; (UPDATED)</image:title>
      <image:caption>Jeff Bezos indicated that Blue Origin may pursue an initial public offering (IPO) several years from now, following a recent $10 billion funding round that valued the company at $140 billion. This funding marks Blue Origin&#39;s first major capital raise from outside investors, as Bezos had previously opted to avoid outside funding until now. The company has secured significant contracts from NASA and the U.S. Space Force and is preparing to resume launches of its New Glenn rocket in December.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/SAIQ:1791462762587</loc>
    <lastmod>2026-10-08T12:32:42.587Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/SAIQ/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>WISeSat.Space Holdings, FOSSA Systems Confirm New Satellite Launch Expected This Month</image:title>
      <image:caption>WISeSat.Space Holdings Corp. (Nasdaq: SAIQ) and FOSSA Systems have announced a new satellite launch scheduled for October 2026. This launch will initiate a series of missions aimed at developing the Quantum Spatial Orbital Cloud (QSOC), which focuses on creating decentralized, quantum-resilient, and sovereign space infrastructure.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/ARM:1791462684683</loc>
    <lastmod>2026-10-08T12:31:24.683Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/08/Arm-Company-Logo-Seen-On-Stm32-Microchip.jpg?width=250&amp;height=187</image:loc>
      <image:title>Why Is Arm Stock Falling Thursday?</image:title>
      <image:caption>Arm Holdings plc (NASDAQ: ARM) stock fell over 3% in Thursday&#39;s premarket trading, following a 2.71% decline the previous day, due to weakness in technology stocks and an ongoing legal dispute with Qualcomm. The trial, which began on Monday, involves billions in potential royalty payments, with Qualcomm alleging that Arm&#39;s actions reduced the value of a deal with Meta by $170 million. Despite a 76.51% gain over the past year, Arm&#39;s high valuation and short-term momentum concerns may lead to profit-taking, as the stock trades below key moving averages.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/DELL:1791462662211</loc>
    <lastmod>2026-10-08T12:31:02.211Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/DELL/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Social Media Discussion: $DELL</image:title>
      <image:caption>Michael Dell defends the decision to shift Trump accounts to individual company stocks, sparking mixed reactions on Reddit. The overall sentiment appears neutral, with users expressing varying opinions on the move.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/MSFT:1791462657328</loc>
    <lastmod>2026-10-08T12:30:57.328Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/MSFT/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Social Media Discussion: $MSFT</image:title>
      <image:caption>Bullish sentiment as Meta and Microsoft reduce reliance on Anthropic, focusing on internal AI tools. The discussions highlight a shift towards investing in artificial general intelligence (AGI) amidst an AI capital expenditure boom.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/CRWD:1791462648566</loc>
    <lastmod>2026-10-08T12:30:48.566Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/CRWD/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Amerx Initiates Coverage On CrowdStrike Holdings with Underweight Rating, Announces Price Target of $212</image:title>
      <image:caption>Amerx analyst Casey Ryan has initiated coverage on CrowdStrike Holdings (NASDAQ: CRWD) with an Underweight rating and set a price target of $212 for the stock.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/NBIS:1791462526778</loc>
    <lastmod>2026-10-08T12:28:46.778Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/NBIS/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Rosenblatt Initiates Coverage On Nebius Group with Buy Rating, Announces Price Target of $304</image:title>
      <image:caption>Rosenblatt analyst John McPeake has initiated coverage on Nebius Group (NASDAQ: NBIS) with a Buy rating. The analyst has set a price target of $304 for the company&#39;s stock.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/AVO:1791462519109</loc>
    <lastmod>2026-10-08T12:28:39.109Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/AVO/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Mission Produce Targets Mid-Single-Digit Organic Sales Growth, 300 Basis Points Of Margin Expansion Over The Next Five Years; Aims To Double Sales And Triple Adj EBITDA By FY35; Reaffirms H2 FY26 Adj EBITDA Outlook Of $84M-$88M; Reaffirming Its Previously Provided Outlook For H2, Q4 2026</image:title>
      <image:caption>Mission Produce aims for mid-single-digit organic sales growth and a 300 basis points margin expansion over the next five years. The company plans to double its sales and triple its adjusted EBITDA by fiscal year 2035. Additionally, Mission Produce has reaffirmed its adjusted EBITDA outlook for the second half of fiscal year 2026, projecting figures between $84 million and $88 million.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/HALO:1791462255022</loc>
    <lastmod>2026-10-08T12:24:15.022Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/HALO/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>HC Wainwright &amp;amp; Co. Maintains Buy on Halozyme Therapeutics, Raises Price Target to $130</image:title>
      <image:caption>HC Wainwright &amp; Co. analyst Mitchell S. Kapoor has maintained a Buy rating on Halozyme Therapeutics (NASDAQ: HALO) and raised the price target from $115 to $130.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/OPTT:1791462037657</loc>
    <lastmod>2026-10-08T12:20:37.657Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/OPTT/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Ocean Power Technologies Receives Order From Naval Postgraduate School For WAM-V 8 Maritime Drone</image:title>
      <image:caption>Ocean Power Technologies, Inc. (NYSE: OPTT) has received an order from the Naval Postgraduate School for a WAM-V® 8 maritime drone. This order highlights the company&#39;s position as a leader in maritime operational infrastructure and autonomous ocean systems.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/SAIL:1791461859707</loc>
    <lastmod>2026-10-08T12:17:39.707Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/SAIL/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Baird Maintains Outperform on SailPoint, Raises Price Target to $25</image:title>
      <image:caption>Baird analyst Shrenik Kothari has maintained an Outperform rating on SailPoint (NASDAQ: SAIL) and increased the price target from $22 to $25. This adjustment reflects a positive outlook on the company&#39;s performance.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/GFS:1791461774431</loc>
    <lastmod>2026-10-08T12:16:14.431Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/GFS/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>GlobalFoundries Reaches Deal With TSMC To Create U.S.-Based Supply Of Silicon Interposers For TSMC&amp;#39;s CoWoS Advanced Packaging Ecosystem</image:title>
      <image:caption>GlobalFoundries (NASDAQ: GFS) has entered into a manufacturing agreement with TSMC to produce silicon interposers in the U.S. for TSMC&#39;s CoWoS advanced packaging ecosystem. This deal will involve expanding fabrication capacity at GlobalFoundries&#39; facility in Malta, New York, to meet the increasing demand for high-performance computing and AI systems. The agreement also sets the stage for future capacity expansion as customer demand rises.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/GFS:1791461720365</loc>
    <lastmod>2026-10-08T12:15:20.365Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/GFS/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>GlobalFoundries Reaches Deal With TSMC To Create U.S.-Based Supply Of Silicon Interposers For TSMC&amp;#39;s CoWoS Advanced Packaging Ecosystem</image:title>
      <image:caption>GlobalFoundries (GFS) has entered into a manufacturing agreement with TSMC to create a U.S.-based supply of silicon interposers for TSMC&#39;s CoWoS advanced packaging ecosystem. This deal will involve expanding fabrication capacity at GlobalFoundries&#39; Malta, New York facility to meet the increasing demand for high-performance computing and AI systems. The agreement also sets the stage for future capacity expansion as customer demand rises.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/GOOG:1791461702142</loc>
    <lastmod>2026-10-08T12:15:02.142Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/GOOG/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Google Cloud Rolls Out Gemini Agent</image:title>
      <image:caption>Google Cloud has launched the Gemini Agent, a new AI tool designed to enhance productivity and streamline workflows for businesses. This rollout is part of Google&#39;s ongoing efforts to integrate advanced AI capabilities into its cloud services. The introduction of Gemini Agent is expected to strengthen Google&#39;s competitive position in the cloud computing market, particularly against rivals like Amazon Web Services and Microsoft Azure.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/GFS:1791461647779</loc>
    <lastmod>2026-10-08T12:14:07.779Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/GFS/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>GlobalFoundries Reaches Deal With TSMC To Create U.S.-Based Supply Of Silicon Interposers For TSMC&amp;#39;s CoWoS Advanced Packaging Ecosystem</image:title>
      <image:caption>GlobalFoundries (NASDAQ: GFS) has entered into a manufacturing agreement with TSMC to create a U.S.-based supply of silicon interposers for TSMC&#39;s CoWoS advanced packaging ecosystem. The deal includes an expansion of fabrication capacity at GlobalFoundries&#39; Malta, New York facility to meet the increasing demand for high-performance computing and AI systems. This agreement sets the stage for future capacity expansion as customer demand rises.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/ARGX:1791461624488</loc>
    <lastmod>2026-10-08T12:13:44.488Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/08/Stuttgart--Germany---Dec-13--2021-Person.jpg?width=250&amp;height=187</image:loc>
      <image:title>Argenx Halts Phase 3 Study in Rare Disease Following Futility Analysis</image:title>
      <image:caption>Argenx SE (NASDAQ: ARGX) announced positive Phase 2 trial results for its experimental drug FB102 in adults with celiac disease, meeting its primary endpoint and demonstrating consistent efficacy across various measures. However, the company has discontinued its Phase 3 UNITY trial for efgartigimod in Sjögren&#39;s disease after an Independent Data Monitoring Committee recommended stopping the study for futility. Following these updates, Argenx shares fell by 15.34% to $786.00 in premarket trading.</image:caption>
    </image:image>
  </url>
</urlset>